Xemio: Feasibility Study of an mHealth App for Breast Cancer Survivors

A European clinical study evaluated the Xemio-Research mobile health application for breast cancer survivors over one year. Maria-Angeles Fuentes-Expósito authored this dataset, which contains results from 61 enrolled participants, 49 of whom actively used the app. The study assessed user adherence, system usability, and patient experience, comparing app-based symptom tracking with traditional quality-of-life questionnaires.

Use Cases

• Analyzing mHealth app engagement trends based on adherence logs showing 96% initial and 35% final trimester usage
• Evaluating digital tool usability based on a validated scale score of 82.78/100
• Comparing symptom tracking methods based on detailed reports for joint pain, tingling, and muscle weakness
• Studying patient feedback patterns based on structured and open-ended survey responses where 87% recommended the app

Strengths

• Includes specific adherence metrics: 96% in first three months declining to 35% in final trimester
• Provides concrete usability score: 82.78 out of 100 from a validated scale
• Contains patient feedback data: 87% recommendation rate from respondents

Limitations

• Row count is unknown, which may limit suitability assessment
• Column-level documentation is absent; field semantics must be inferred after download
• Dataset is very small at 5.5 KB, indicating limited scope

Provenance

Source

figshare

Collection Method

Prospective clinical study where breast cancer survivors installed and used the Xemio-Research app, with data collected via interaction logs, activity tracking, and surveys.

Time Range

Study conducted over one year.

Freshness

Last updated 2026-05-13 17:35:52; freshness should be verified

Geography

Clinical setting in Europe; specific country not stated.